A recent opinion piece in the Anchorage Daily News by Tom Kizzia (“The last refuge”) draws a flawed historical parallel by equating Alaska Native organizations’ reliance on federal intervention for ...
Bimekizumab, a humanised monoclonal antibody, is the first and only dual inhibitor of IL-17A and IL-17F, two pro-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results